ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunogenicity"

  • 2017 American Transplant Congress

    Liver Mesenchymal Stem Cells Inhibit T Cell Alloresponses.

    T. Taner, M. Gustafson, M. Hansen, A. Dietz, M. Stegall.

    Mayo Clinic, Rochester, MN

    Clinical and histologic evidence suggest that the liver allograft induces alloimmune hyporesponsiveness in the recipient. Mesenchymal stem cells (MSC) are multipotent non-hematopoietic stromal cells with…
  • 2017 American Transplant Congress

    Human Islet-Derived Extracellular Vesicles Stimulate CD14+ Monocytes Resulting in Proinflammatory Cytokine Production.

    A. Rutman, S. Negi, C. Hasilo, M. Gasparrini, J. Tchervenkov, S. Paraskevas.

    Department of Surgery, McGill University Health Centre, Montreal, QC, Canada

    Introduction: The cellular events involved in the generation of an auto and allo-reactive immune response in recipients of islet transplantation are not well understood. In…
  • 2017 American Transplant Congress

    Identification of NKG2D as Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.

    T. Resch,1 J. Günther,1 H. Hackl,2 A. Sattler,3 S. Ebner,1 P. Ritschl,3 M. Biebl,3 R. Öllinger,3 S. Schneeberger,1 G. Brandacher,4 H. Schwelberger,1 B. Zelger,5 D. Stauch,3 A. Pascher,3 J. Pratschke,3 K. Kotsch.3

    1Center of Operative Medicine, Department for Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria; 2Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria; 3Department for General, Visceral and Transplantation Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany; 4Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, John Hopkins University School of Medicine, Baltimore; 5Institute of Pathology, Medical University of Innsbruck, Innsbruck, Austria

    The definition of biological donor organ age rather than chronological age seems an obvious factor for the establishment of valid pre-transplant risk assessment. We therefore…
  • 2016 American Transplant Congress

    Biopsy-Proven Rejection in Children After Liver Transplantation Is Associated by an IL-12p40-Mediated Innate Immune Response Followed by Th1 T Cell Activation.

    C. Falk,1 I. Goldschmidt,2 F. Mutschler,2 E. Pfister,2 F. Lehner,3 J. Keil,1 C. Neudörfl,1 A. Karch,4 R. Mikolajczyk,4 U. Baumann.2

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Bitte Wählen, Germany; 2Department of Pediatric Hepatology, Hannover Medical School, Hannover, Bitte Wählen, Germany; 3Department of Abdominal and Transplantation Surgery, Hannover Medical School, Hannover, Bitte Wählen, Germany; 4Department of Epidemiology, Helmholtz Center for Infection Research, HZI, Braunschweig, Germany.

    Sustained by adaptive immune cells and their soluble mediators is well established for infection but it has not been demonstrated for solid organ transplantation in…
  • 2016 American Transplant Congress

    Potent Induction Therapy Improves Graft Outcome in Younger Pancreas Transplant Recipients (<30 Years of Age).

    A. Gruessner, V. Whittaker, S. Narsipur, V. Aggarwal, C. Hubbel, R. Gruessner.

    SUNY Upstate Medical University, Syracuse, NY.

    Purpose: Pancreas transplants (tx) are increasingly performed in older patients with type 1 diabetes mellitus. This trend may be explained by the significantly higher immunologic…
  • 2016 American Transplant Congress

    Assessing Return of CMV Specific Cellular Immunity Using the T-SPOT.CMV Soon After Kidney Transplant with Thymoglobulin.

    C. Kotton.

    Infectious Disease, Massachusetts General Hospital, Boston, MA.

    Background: We do not currently have sufficient predictive tools to determine risk of CMV infection after organ transplantation. Recent data suggest that assays of the…
  • 2016 American Transplant Congress

    Differential Regulation of the Microvascular Endothelial Cell Mediated Allogeneic CD4+ T Cell Response by Anti-HLA-DR and -DQ Alloantibodies in an Inflammatory Context.

    N. Mooney,1,2 A. Cross,1,2 J. Lion,1,2 A. Haziot,1,2 D. Glotz.1,2,3

    1INSERM UMRS 1160, Institut Universitaire d'Hématologie, Paris, France; 2Université-Paris-Diderot, Sorbonne Paris Cité, Paris, France; 3Service de Néphrologie et Transplantation, Hôpital Saint Louis, Paris, France.

    This study examines the basic mechanisms by which high levels of circulating HLA class II donor-specific-antibodies can contribute to microvasculature damage in chronic antibody mediated…
  • 2016 American Transplant Congress

    Blocking MHC Class II on Human Endothelium Mitigates Acute Rejection of Vessel Allografts by Effector Memory T Cells.

    P. Abrahimi,1 L. Qin,2 W. Chang,1 A. Bothwell,1 G. Tellides,2 W. Saltzman,3 J. Pober.1

    1Immunobiology, Yale School of Medicine, New Haven, CT; 2Surgery, Yale School of Medicine, New Haven, CT; 3Biomedical Engineering, Yale University, New Haven, CT.

    Acute allograft rejection is mediated by alloreactive CD8+ T cells that differentiate into cytotoxic lymphocytes (CTL). In most rodent models, CTL differentiate from naïve CD8+…
  • 2016 American Transplant Congress

    Everolimus in Combination with Reduced Dose Tacrolimus Is Effective as a Prophylaxis of Acute Rejection in Low-to-Moderate Immunologic Risk De Novo Kidney Transplantation Patients.

    Y. Qazi, F. Shihab, S. Mulgaonkar, K. MaCague, D. Patel.

    University of Southern California, Los Angeles; University of Utah, Salt Lake City; Barnabas Health, West Orange; Novartis Pharmaceuticals Corporation, East Hanover.

    The US92 study determined whether, in de novo renal transplant patients (pts), concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior compared to CellCept®…
  • 2016 American Transplant Congress

    Delayed Induction of Mixed Chimerism Permits Kidney-Induced Cardiac Allograft Tolerance to be Applied to Recipients of Cadaveric Organs.

    M. Tonsho,1 G. Benichou,1 R. Yu,1 S. Boskovic,1 R. Colvin,1,2 E. Farkash,2 R.-N. Smith,2 J. Allan,1,4 A. Cosimi,1 T. Kawai,1,3 J. Madsen.1,4

    1Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA; 2Department of Pathology, Massachusetts General Hospital, Boston, MA; 3Department of Surgery, Massachusetts General Hospital, Boston, MA; 4Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA.

    (BACKGROUND)Cardiac tolerance in nonhuman primates (NHPs) has been induced for the first time by kidney co-transplantation in combination with donor bone marrow infusion when the…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences